A Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
about
A Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Safety and Pharmacokinetic S ...... nic Lymphocytic Leukemia (CLL)
@en
type
label
A Safety and Pharmacokinetic S ...... nic Lymphocytic Leukemia (CLL)
@en
prefLabel
A Safety and Pharmacokinetic S ...... nic Lymphocytic Leukemia (CLL)
@en
P17
P6153
P1476
An Open-Label, Multicenter, Ph ...... d Chronic Lymphocytic Leukemia
@en
P3098
NCT02500407
P4844
P580
2015-09-30T00:00:00Z
P582
2019-09-02T00:00:00Z